Shanghai Shen Lian Biomedical Corp (688098) — Tangible Net Worth Ratio
Shanghai Shen Lian Biomedical Corp (688098) has a Tangible Net Worth Ratio of 90.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥138.40 Million) from net assets (CN¥1.40 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 688098 book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shanghai Shen Lian Biomedical Corp Tangible Net Worth Ratio (2013–2025)
This chart shows how Shanghai Shen Lian Biomedical Corp's Tangible Net Worth Ratio has changed across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 90.1%, reflecting net assets of CN¥1.40 Billion with intangible assets of CN¥138.40 Million CNY. Also explore 688098 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Shanghai Shen Lian Biomedical Corp (2013–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Shanghai Shen Lian Biomedical Corp from 2013 to 2025, covering 13 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Shanghai Shen Lian Biomedical Corp (688098) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 90.0% | CN¥1.40 Billion | CN¥140.10 Million | CN¥1.54 Billion | ▼ -0.5 pp |
| 2024 | 90.5% | CN¥1.43 Billion | CN¥135.85 Million | CN¥1.55 Billion | ▼ -0.5 pp |
| 2023 | 91.0% | CN¥1.51 Billion | CN¥135.95 Million | CN¥1.59 Billion | ▼ -2.7 pp |
| 2022 | 93.6% | CN¥1.50 Billion | CN¥95.29 Million | CN¥1.61 Billion | ▼ -1.7 pp |
| 2021 | 95.4% | CN¥1.47 Billion | CN¥68.18 Million | CN¥1.60 Billion | ▼ -2.1 pp |
| 2020 | 97.5% | CN¥1.40 Billion | CN¥35.11 Million | CN¥1.51 Billion | ▲ +0.1 pp |
| 2019 | 97.4% | CN¥1.28 Billion | CN¥33.83 Million | CN¥1.45 Billion | ▲ +1.5 pp |
| 2018 | 95.9% | CN¥831.94 Million | CN¥34.44 Million | CN¥1.01 Billion | ▲ +2.3 pp |
| 2017 | 93.6% | CN¥549.27 Million | CN¥35.24 Million | CN¥692.19 Million | ▲ +1.3 pp |
| 2016 | 92.3% | CN¥465.47 Million | CN¥36.03 Million | CN¥607.79 Million | ▲ +3.9 pp |
| 2015 | 88.4% | CN¥317.41 Million | CN¥36.82 Million | CN¥490.32 Million | ▲ +4.0 pp |
| 2014 | 84.4% | CN¥241.57 Million | CN¥37.65 Million | CN¥528.89 Million | ▼ -13.8 pp |
| 2013 | 98.2% | CN¥327.59 Million | CN¥5.95 Million | CN¥531.53 Million | — |